Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis
Completed · Phase 4 · Has a placebo group
Conditions studied: Chronic Plaque Psoriasis
In brief
This study evaluated the effect of secukinumab compared to placebo on aortic vascular inflammation in adult patients who have moderate to severe plaque psoriasis that is poorly controlled by current psoriasis treatments.
Key facts
- Study ID
- NCT02690701
- Run by
- Novartis Pharmaceuticals
- People needed
- 91
- Starts
- 2016-02-10
- Expected to finish
- 2018-02-19
- Last updated by the study team
- 2021-01-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Males and females at least 18 years of age with moderate to severe plaque psoriasis
You may not qualify if…
- Forms of psoriasis other than chronic plaque psoriasis
- Previous exposure to IL-17A or IL-17 receptor targeting agents.
- Other active or ongoing disease that may interfere with evaluation of psoriasis or places the patient at unacceptable risk
- Other protocol-defined inclusion/exclusion criteria may apply
Where it is running
- Novartis Investigative Site — Los Angeles, California, United States
- Novartis Investigative Site — Santa Ana, California, United States
- Novartis Investigative Site — Rockville, Maryland, United States
- Novartis Investigative Site — St Louis, Missouri, United States
- Novartis Investigative Site — Buffalo, New York, United States
- Novartis Investigative Site — New York, New York, United States
- Novartis Investigative Site — Portland, Oregon, United States
- Novartis Investigative Site — Portland, Oregon, United States
- Novartis Investigative Site — Exton, Pennsylvania, United States
- Novartis Investigative Site — Dallas, Texas, United States
- Novartis Investigative Site — Houston, Texas, United States
- Novartis Investigative Site — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.